The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signalling in platelets.

Jennifer Spalton, J Mori, Alice Pollitt, Craig Hughes, JA Eble, Steve Watson

Research output: Contribution to journalArticlepeer-review

68 Citations (Scopus)
237 Downloads (Pure)

Fingerprint

Dive into the research topics of 'The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signalling in platelets.'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science